[{"AccountsPayableCurrent_0_Q1_USD":5839000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":41000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-3073000.0,"MarketableSecuritiesCurrent_0_Q1_USD":71826000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":141000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":6404000.0,"ProceedsFromIssuanceOfDebt_1_Q1_USD":25000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2707000.0,"OtherLiabilitiesCurrent_0_Q1_USD":352000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":2326000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2707000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":14191000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":4.94,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":76000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":56000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-19595000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1099000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":373000.0,"InterestExpenseDebt_1_Q1_USD":200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-19732000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":297374000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":43580000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":181000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":153000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":127462000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.0079,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.0162,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.7315,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.7734,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":7152000.0,"RestrictedCashNoncurrent_0_Q1_USD":15000.0,"RepaymentsOfDebt_1_Q1_USD":10000000.0,"ProceedsFromStockPlans_1_Q1_USD":646000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":3600000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q1_USD":0.0,"OtherNoncashIncomeExpense_1_Q1_USD":19000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-137000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"InvestmentIncomeNonoperating_1_Q1_USD":641000.0,"IncreaseDecreaseInDeferredCharges_1_Q1_USD":36000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":15113000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":22873000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":38605000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":43580000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":127490000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":48500000.0,"DebtInstrumentInterestRateDuringPeriod_1_Q1_pure":0.0809,"OtherAssetsNoncurrent_0_Q1_USD":2683000.0,"LongTermDebtNoncurrent_0_Q1_USD":24155000.0,"InterestPayableCurrentAndNoncurrent_0_Q1_USD":200000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":763000.0,"NetIncomeLoss_1_Q1_USD":-19595000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-18734000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":41637000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":15702000.0,"LiabilitiesCurrent_0_Q1_USD":32008000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":153875000.0,"Liabilities_0_Q1_USD":71790000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1417000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":2781000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8713000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.84,"CommonStockValue_0_Q1_USD":23000.0,"CommonStockSharesOutstanding_0_Q1_shares":23227421.0,"CommonStockSharesIssued_0_Q1_shares":23227421.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":43565000.0,"AssetsCurrent_0_Q1_USD":127459000.0,"Assets_0_Q1_USD":153875000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6065721.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":28000.0,"AccountsReceivableNetCurrent_0_Q1_USD":9079000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2989000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":646000.0,"ProfitLoss_1_Q1_USD":-19595000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-215340000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":255000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":8693572.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":86000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-745000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":56000.0,"ShareBasedCompensation_1_Q1_USD":2707000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":17619000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-19180000.0,"OperatingExpenses_1_Q1_USD":26332000.0,"InterestPaidNet_1_Q1_USD":134000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AccruedLiabilitiesCurrent_0_Q1_USD":2944000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":23197971.0,"StockholdersEquity_0_Q1_USD":82085000.0,"RevenueFromRelatedParties_1_Q1_USD":2813000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":9527000.0,"UnrealizedGainLossOnDerivativesAndCommodityContracts_1_Q1_USD":-7000.0,"Ticker":"STRO","CIK":"1382101","name":"SUTRO BIOPHARMA, INC.","OfficialName":"Sutro Biopharma Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"326059920.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]